54575-191 : Chaetomium Globosum 1 g/20ml Percutaneous; Subcutaneous Injection, Solution


NDC: 54575-191
Labeler: Allergy Laboratories, Inc.
Product Type: Human Prescription Drug
Drug Name: Chaetomium Globosum
Dosage Form: Percutaneous; Subcutaneous Injection, Solution
Application #: BLA101376
Rev. Date: 


NDC Package Codes:

  • 54575-191-02: 2 ML IN 1 VIAL, MULTI‑DOSE (54575‑191‑02)
  • 54575-191-10: 10 ML IN 1 VIAL, MULTI‑DOSE (54575‑191‑10)
  • 54575-191-30: 30 ML IN 1 VIAL, MULTI‑DOSE (54575‑191‑30)
  • 54575-191-50: 50 ML IN 1 VIAL, MULTI‑DOSE (54575‑191‑50)

Active Ingredients:

  • Chaetomium Globosum

Dosage Strength:

  • 1 g/20mL

Pharmaceutical Classes:

  • Non-Standardized Fungal Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Fungal Proteins [CS]
  • Allergens [CS]

Related Products:

Based on records with the same trade name.
  • 0268-0851 Chaetomium Globosum 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0852 Chaetomium Globosum 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0853 Chaetomium Globosum 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-6516 Chaetomium Globosum .1 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-6517 Chaetomium Globosum 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.
  • 22840-1647 Chaetomium Globosum .1 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-1648 Chaetomium Globosum 40000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-1650 Chaetomium Globosum 20000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-1651 Chaetomium Globosum .001 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-5612 Chaetomium Globosum .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 36987-1947 Chaetomium Globosum 10000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1948 Chaetomium Globosum 10000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1949 Chaetomium Globosum 20000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1950 Chaetomium Globosum 20000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1951 Chaetomium Globosum 40000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1952 Chaetomium Globosum .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1953 Chaetomium Globosum .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1954 Chaetomium Globosum .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1955 Chaetomium Globosum .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 54575-191 QR Code

< Prev: 54575-190Next: 54575-192 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.